BWX Technologies (NYSE:BWXT) Hits New 52-Week Low - What's Next?

Key Points

• BWX Technologies shares fell to a new 52-week low of $144.00, well below their 50-day and 200-day moving averages of $162.71 and $190.00, respectively.
• Analyst sentiment remains generally positive, with a “Moderate Buy” consensus and an average price target of $217.92, although some firms recently downgraded the stock or reduced their targets.
• The company exceeded quarterly earnings expectations, reporting $1.07 in EPS and 18% year-over-year revenue growth. BWXT also pays a quarterly dividend of $0.27 per share, while its CEO recently sold 10,000 shares under a pre-arranged trading plan.

BWX Technologies, Inc. (NYSE:BWXT - Get Free Report)'s share price hit a new 52-week low during mid-day trading on Tuesday . The company traded as low as $144.00 and last traded at $144.5850, with a volume of 160614 shares trading hands. The stock had previously closed at $147.47.

Analysts Set New Price Targets

BWXT has been the subject of several recent research reports. Seaport Research Partners raised shares of BWX Technologies from a "neutral" rating to a "buy" rating and set a $245.00 target price for the company in a report on Monday, June 22nd. JPMorgan Chase & Co. began coverage on BWX Technologies in a research note on Monday, July 27th. They set an "overweight" rating and a $230.00 target price for the company. Wall Street Zen lowered shares of BWX Technologies from a "buy" rating to a "hold" rating in a research note on Saturday, August 8th. Truist Financial lowered their target price on shares of BWX Technologies from $212.00 to $202.00 and set a "hold" rating on the stock in a research note on Friday, August 14th. Finally, Weiss Ratings lowered BWX Technologies from a "buy (b-)" rating to a "hold (c+)" rating in a research report on Wednesday, August 26th. Two equities research analysts have rated the stock with a Strong Buy rating, eight have issued a Buy rating and five have issued a Hold rating to the company's stock. According to data from MarketBeat, the company has an average rating of "Moderate Buy" and a consensus target price of $217.92.

BWX Technologies Price Performance

The stock has a fifty day simple moving average of $162.71 and a 200-day simple moving average of $190.00. The company has a current ratio of 2.40, a quick ratio of 2.33 and a debt-to-equity ratio of 1.51. The company has a market capitalization of $13.34 billion, a PE ratio of 37.71, a P/E/G ratio of 2.31 and a beta of 0.75.

BWX Technologies (NYSE:BWXT - Get Free Report) last released its quarterly earnings data on Monday, August 3rd. The technology company reported $1.07 earnings per share for the quarter, topping analysts' consensus estimates of $1.04 by $0.03. The company had revenue of $901.62 million for the quarter, compared to analysts' expectations of $902.41 million. BWX Technologies had a net margin of 10.11% and a return on equity of 30.83%. The firm's revenue for the quarter was up 18.0% on a year-over-year basis. During the same quarter last year, the company earned $1.02 earnings per share. BWX Technologies has set its FY 2026 guidance at 4.700-4.800 EPS. Equities analysts anticipate that BWX Technologies, Inc. will post 4.75 earnings per share for the current year.

BWX Technologies Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, September 4th. Shareholders of record on Tuesday, August 18th were given a dividend of $0.27 per share. The ex-dividend date was Tuesday, August 18th. This represents a $1.08 dividend on an annualized basis and a yield of 0.7%. BWX Technologies's dividend payout ratio is presently 27.98%.

Insider Transactions at BWX Technologies

In other BWX Technologies news, CEO Rex D. Geveden sold 10,000 shares of the firm's stock in a transaction on Wednesday, August 12th. The stock was sold at an average price of $172.50, for a total value of $1,725,000.00. Following the completion of the sale, the chief executive officer owned 192,491 shares of the company's stock, valued at approximately $33,204,697.50. This trade represents a 4.94% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 0.60% of the company's stock.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of BWXT. M.D. Sass LLC purchased a new stake in BWX Technologies during the 2nd quarter worth $2,619,000. Ranger Investment Management L.P. bought a new stake in BWX Technologies in the first quarter valued at about $11,991,000. Intech Investment Management LLC raised its position in shares of BWX Technologies by 22.7% during the 4th quarter. Intech Investment Management LLC now owns 32,668 shares of the technology company's stock valued at $5,646,000 after acquiring an additional 6,053 shares in the last quarter. Silvant Capital Management LLC acquired a new stake in shares of BWX Technologies during the second quarter worth $6,574,000. Finally, Insight Wealth Strategies LLC bought a new position in BWX Technologies in the second quarter worth about $5,949,000. 94.39% of the stock is currently owned by institutional investors and hedge funds.

BWX Technologies Company Profile

BWX Technologies, Inc NYSE: BWXT is a technology and manufacturing company that specializes in nuclear components, systems and services. The company primarily serves government and commercial customers in the nuclear energy, national security and medical markets.

BWXT is a major supplier to the U.S. government and supports the U.S. Navy's nuclear propulsion program by designing and manufacturing nuclear reactors and related components for naval vessels. Its offerings also include nuclear fuel, reactor components, engineering and maintenance services, and technologies intended for advanced and small modular reactors.

Through its commercial and medical businesses, BWXT provides nuclear equipment and services for civilian power generation, produces medical radioisotopes and related technologies, and supports research and other specialized applications.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.